ANDREW WIRTH: Open Payments
NPI 1619605250 · GREENSBORO, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$860 in 60 payments from 11 companies in 2025. Trend: 2023 $310 · 2024 $640 · 2025 $860
Food & beverage: $860
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 17 | $173 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 12 | $157 |
| Supernus Pharmaceuticals, Inc. | 9 | $152 |
| Otsuka America Pharmaceutical, Inc. | 6 | $112 |
| Lundbeck LLC | 5 | $86 |
| Takeda Pharmaceuticals U.S.A., Inc. | 5 | $72 |
| Janssen Pharmaceuticals, Inc | 2 | $40 |
| Axsome Therapeutics, Inc. | 1 | $20 |
| Tris Pharma Inc | 1 | $17 |
| Vanda Pharmaceuticals Inc. | 1 | $16 |
Products named: REXULTI, VRAYLAR, CAPLYTA, Qelbree, TRINTELLIX, SPRAVATO, Auvelity, Dyanavel XR.
Industry payments across NC — which companies pay providers there.
